Skip to main content
OpenTrials

Clinical trial condition

Endocrine Gland Neoplasms

Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.

6,097 public trials 1,370 recruiting studies
Refine in advanced search Browse all conditions

Endocrine Gland Neoplasms trial results

Completed

A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women

NCT01121640

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
Locations
  • City of Hope Duarte, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Stanford University Stanford, California, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Trial of Pimasertib With SAR245409 or Placebo in Ovarian Cancer

NCT01936363

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Research site Augusta, Georgia, United States
  • Research site Chicago, Illinois, United States
  • Research site Indianapolis, Indiana, United States
  • Research site Silver Spring, Maryland, United States
View all 34 locations
View Trial Details
Completed

Study of Gemcitabine + PEGPH20 vs Gemcitabine Alone in Stage IV Previously Untreated Pancreatic Cancer

NCT01453153

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • California Pacific Medical Center San Francisco, California, United States
  • Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • UMDNJ - New Jersey Medical School Newark, New Jersey, United States
View Trial Details
Completed

Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131

NCT00085293

Conditions
Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +18 more
Locations
  • University of Colorado at Denver Aurora, Colorado, United States
  • Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse

NCT02960594

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Cancer, +53 more
Locations
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions